approval · primary record
ADALIMUMAB-ADBM
FDA · BLA · 2025-10-16
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-16 |
| Brand | CYLTEZO |
| Sponsor | BOEHRINGER INGELHEIM |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:02.662Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ADALIMUMAB-ADBM:2025-10-16
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.